SymbolNXL
NameNEXALIN TECHNOLOGY, INC.
SectorHEALTH CARE
RegionNorth America
IndustryBiotechnology: Electromedical & Electrotherapeutic Apparatus
Address1776 YORKTOWN,SUITE 550, HOUSTON, Texas, 77056, United States
Telephone+1 832 - 260-0222
Fax
Email
Websitehttps://www.nexalin.com
IncorporationUNDEFINED
Incorporated On
Employees
Fiscal Year
Public Since
ExchangesNASDAQ
Auditor
Audit StatusNOT PROVIDED
Reporting Status
CIK0001527352
Description

Nexalin Technology Inc design and develop innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic.

Additional info from NASDAQ:
Nexalin Technology Inc design and develop innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic.

2026-08-21 21:20

(99% Neutral) NEXALIN TECHNOLOGY, INC. (NXL) Announces Business Combination

Read more
2026-08-20 21:28

(99% Neutral) NEXALIN TECHNOLOGY, INC. (NXL) Announces Business Combination

Read more
2026-08-20 18:24

New Form 424B5 - Nexalin Technology, Inc. <b>Filed:</b> 2026-08-20 <b>AccNo:</b> 0001829126-26-009171 <b>Size:</b> 293 KB

Read more
2026-08-17 13:00

(99% Neutral) NEXALIN TECHNOLOGY, INC. (NXL) Files Form 8-K

Read more
2026-08-11 20:15

(99% Neutral) NEXALIN TECHNOLOGY, INC. (NXL) Files Form 8-K

Read more
2026-07-29 21:25

(99% Neutral) NEXALIN TECHNOLOGY, INC. (NXL) Announces Business Combination

Read more
2026-07-27 21:25

(99% Neutral) NEXALIN TECHNOLOGY, INC. (NXL) Files Form 8-K

Read more
2026-06-29 18:30

New Form PRE 14A - Nexalin Technology, Inc. <b>Filed:</b> 2026-06-29 <b>AccNo:</b> 0001829126-26-007001 <b>Size:</b> 2 MB

Read more
2026-06-23 12:30

Nexalin Technology Announces that the Investigator of Its Brazilian Clinical Trial Received the Young Researcher Award at BRAIN 2026 for Research Evaluating the Company’s Proprietary DIFS™ Platform

Read more
2026-06-17 21:00

(99% Neutral) NEXALIN TECHNOLOGY, INC. (NXL) Announces Executive Changes

Read more
Trial ID Title Phase Indication Status Start Date Completion Date Source
NCT07659366 HALO Clarity™ Cranial Alternating Current Stimulation Therapy for Adults With M… Na Moderate to Severe Insomnia Not_Yet_Recruiting 2026-06-22 2027-10-25 ClinicalTrials.gov
Total clinical trials: 1
Product Name Type Development Stage Therapeutic Area Study Status Trial ID
Transcranial alternating current stimulator Other Approved Moderate to Severe Insomnia NOT_YET_RECRUITING NCT07659366
Total products: 1